HAVN Life Sciences Inc. (HAVLF)
Extracts and develops psychoactive compounds from mushrooms for medical research and products
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-50.0%
The outlook
HAVLF is trading near its 52-week lows at a penny-stock price level, with mixed momentum against its moving averages. Analyst coverage appears sparse or absent. The overall data leans bearish, reflecting the stock's position at the extreme bottom of its recent range.
What’s behind the score
Price trendMixed vs its moving averages
52-week range1% of the way from its 52-week low to high
Market cap
$1,473
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—